• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Paul M. Busse, M.D. Ph.D.


  • McBride SM, Busse PM, Clark JR, Wirth LJ, Ancukiewicz M, Chan AW.Long-term survival after distant metastasis in patients with oropharyngeal cancer.Oral Oncol. 2014 Mar;50(3):208-12.
  • Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M, .Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines.J Natl Compr Canc Netw. 2013 Aug;11(8):917-23.
  • McBride SM, Parambi RJ, Jang JW, Goldsmith T, Busse PM, Chan AW.Intensity-modulated versus conventional radiation therapy for oropharyngeal carcinoma: Long-term dysphagia and tumor control outcomes.Head Neck. 2013 Jun 1.
  • Nichols AC, Kneuertz PJ, Deschler DG, Lin DT, Emerick KS, Clark JR, Busse PW, Rocco JW.Surgical salvage of the oropharynx after failure of organ-sparing therapy.Head Neck. 2010 Jul 22.
  • Nichols AC, Finkelstein DM, Faquin WC, Westra WH, Mroz EA, Kneuertz P, Begum S, Michaud WA, Busse PM, Clark JR, Rocco JW.Bcl2 and Human Papilloma Virus 16 as Predictors of Outcome following Concurrent Chemoradiation for Advanced Oropharyngeal Cancer.Clin Cancer Res. 2010 Apr 1;16(7):2138-46.
  • Michaud WA,Nichols AC,Mroz EA,Faquin WC,Clark JR,Begum S,Westra WH,Wada H,Busse PM,Ellisen LW,Rocco JW.Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma.Clin Cancer Res. 2009 Mar 1;15(5):1645-54.
  • Lawenda BD,Arnold MG,Tokarz VA,Silverstein JR,Busse PM,McIntyre JF,Deschler DG,Baldini EH,Kachnic LA.Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.Ear Nose Throat J. 2008 Nov;87(11):634-43. Review.
  • Han N, Jarvinen KM, Cocco RR, Busse PJ, Sampson HA, Beyer K.Identification of amino acids critical for IgE-binding to sequential epitopes of bovine kappa-casein and the similarity of these epitopes to the corresponding human kappa-casein sequence.Allergy. 2008 Feb;63(2):198-204.
  • Busse PJ, Zhang TF, Srivastava K, Schofield B, Li XM.Effect of ageing on pulmonary inflammation, airway hyperresponsiveness and T and B cell responses in antigen-sensitized and -challenged mice.Clin Exp Allergy. 2007 Sep;37(9):1392-403.
  • Berns SH, Halm EA, Sampson HA, Sicherer SH, Busse PJ, Wisnivesky JP.Food allergy as a risk factor for asthma morbidity in adults.J Asthma. 2007 Jun;44(5):377-81.
  • Busse PJ.Allergic respiratory disease in the elderly.Am J Med. 2007 Jun;120(6):498-502.
  • Tishler RB, Posner MR, Norris CM, Mahadevan A, Sullivan C, Goguen L, Wirth LJ, Costello R, Case M, Stowell S, Sammartino D, Busse PM, Haddad RI.Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck.Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1036-44.
  • Tishler RB, Busse PM, Norris CM, Rossi R, Poulin M, Thornhill L, Costello R, Peters ES, Colevas AD, Posner MR.An initial experience using concurrent paclitaxel and radiation in the treatment of head and neck malignancies.Int J Radiat Oncol Biol Phys. 1999 Mar 15;43(5):1001-8.
  • Colevas AD, Busse PM, Norris CM, Fried M, Tishler RB, Poulin M, Fabian RL, Fitzgerald TJ, Dreyfuss A, Peters ES, Adak S, Costello R, Barton JJ, Posner MR.Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.J Clin Oncol. 1998 Apr;16(4):1331-9.
  • Clark JR, Busse PM, Norris CM, Andersen JW, Dreyfuss AI, Rossi RM, Poulin MD, Colevas AD, Tishler RB, Costello R, Lucarini JW, Lucarini D, Thornhill L, Lackey M, Peters E, Posner MR.Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results.J Clin Oncol. 1997 Sep;15(9):3100-10.